Charles Rotter

Principal Scientist @Rapport Therapeutics

San Diego, CA, US
EMAILS
c••••••@rapportrx.com
MOBILE NUMBERS
+12•••••••61

Signup · Get unlimited contacts

WORK HISTORY

Aug 2024 — Present

Principal Scientist @Rapport Therapeutics

View department →

San Diego, CA, US

Responsible for representing the Drug Metabolism and Pharmacokinetics (DMPK) functional area. Provide scientific and strategic input in a matrix environment; oversee DMPK studies to support preclinical and clinical development. Design, execute, and manage PK, PK-PD, and drug metabolism studies, integrating ADME, PK, and PK/PD endpoints to guide optimization strategies.Apply understanding of DMPK, physicochemical properties and biotransformation to support/influence compound design, program progression and strategy.Leverage in-depth knowledge of drug transporters to improve CNS drug candidates’ penetrance across blood-brain barrier.Evaluate and interpret in vitro and in vivo DMPK data to address key program challenges.Implement innovative technologies and approaches to address program uncertainties.

EDUCATION

N/A

University of Connecticut

Molecular and Cell Biology

SKILLS

DmpkOncologyReaction PhenotypingCell CultureBiotransformationDrug DiscoveryToxicologyCRODrug DevelopmentBioanalysisEnzymologyPharmaceutical IndustryPharmacokineticsPharmacodynamicsAdmeCellIn VivoDrug DesignLife SciencesDdiAssay DevelopmentCRO ManagementDrug TransportersIn VitroDrug Metabolism

ABOUT CHARLES ROTTER

20+ years of R&D experience focusing in Pharmacokinetics and Drug Metabolism, with emphasis on ADME Technologies and Drug Transporters. Co-authored 25+ publications and 12+ conference presentations.Application of in vitro/in vivo ADME related studies to support discovery and development projects.Investigation of transporter -mediated drug disposition in cancer tissue to facilitate tumor targeting.Specialties: Drug Metabolism and Pharmacokinetics ADME Science Drug Transporters In Vitro - In Vivo Correlation Drug-Drug Interactions Enzymology DMPK High Throughput Screening Drug Discovery & Development Human PK prediction PBPK Program Management Due Diligence IND- enabling

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.